Mulligan Richard's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Sep 26, 2024
- Accession no.
- 0001562180-24-006954
- Filed
- Sep 26, 2024
- Trade date
- Sep 24-25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.20M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulligan RichardCIK 0001376247 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2024 | Common Stock | SSaleDisposed | −150,000 | $4.08 | −$612,000 | 2,848,121 | Direct | |
| Sep 25, 2024 | Common Stock | SSaleDisposed | −150,000 | $3.89 | −$583,500 | 2,698,121 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.